Imperial increases holding in Veryan:
This article was originally published in Clinica
Veryan Medical (Horsham, UK) has received £1.6m ($3.1m) in financial backing from Imperial Innovations, which increased its existing shareholding in the company to 39%. Veryan are aiming to profit from the $5bn stent market with its patented Swirlflow technology used in the treatment of vascular disease. Swirlflow reproduces helical geometry naturally found in the body and introduces a swirling motion to the arteries, in order to reduce restenosis.